Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT

NCT: NCT07534475 · NOT_YET_RECRUITING

NCT IDNCT07534475
StatusNOT_YET_RECRUITING
Start Date2026-04-20
Completion2026-06-20

Brief Summary

This prospective, open-label clinical trial aims to compare a novel "Venous Tourniquet with Regional Low-Dose Sugammadex" method against the gold standard "Arterial Tourniquet" (Isolated Forearm Technique - IFT) for monitoring motor seizure activity during Electroconvulsive Therapy (ECT). Using a within-subject (intra-individual) design, each of the 40 enrolled patients will receive an arterial tourniquet on one arm and a venous tourniquet on the other arm simultaneously. The study will evaluate clinical efficacy in observing motor seizures, comparing the duration and visibility between the two limbs of the same patient, as well as assessing overall patient comfort and hemodynamics.

Frequently Asked Questions

What is Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT?

Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT is a clinical trial registered under NCT07534475. Current status: NOT_YET_RECRUITING.

What is the status of NCT07534475?

The current status of NCT07534475 (Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT) is: NOT_YET_RECRUITING.

When did Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT start?

Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT started on 2026-04-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.